3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy
Clinical trial NCT01751451 · COMPLETED
Trial details
- NCT number
- NCT01751451
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-18
- Primary completion
- 2020-09-28
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.